US 10252997
Monocyclic compound
granted A61KA61K31/165A61K31/167
Quick answer
US patent 10252997 (Monocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/165, A61K31/167, A61K31/277, A61K31/381